Last reviewed · How we verify
esomeprazole, amoxicillin, furazolidone，tetracycline
At a glance
| Generic name | esomeprazole, amoxicillin, furazolidone，tetracycline |
|---|---|
| Sponsor | Shandong University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy (PHASE4)
- Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment (PHASE3)
- The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure
- A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication (PHASE4)
- Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy (PHASE4)
- The Study on the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure
- Differences in the Eradication of Helicobacter Pylori by Different Therapies (NA)
- Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: